Further Information – Prana’s PBT2 Clinical Trials Cited as Most Advanced in Addressing Neurodegeneration from the Metal Equilibrium Perspective July 17, 2013August 16, 2022
First Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial December 14, 2021August 16, 2022
